Sinopia Biosciences, Inc.
PrivateLast Round
Seed Round
Jul 16, 2026
Total Funding Raised
$7.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Sinopia Biosciences, Inc. is a biotechnology company that develops novel therapeutics using its proprietary LEADS drug discovery platform, which integrates high-throughput omics data, AI/machine learning, and network analysis.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sinopia Biosciences, Inc. Comparables
Compare Sinopia Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verge Labs | 80% | |
| Aitia | 79% | |
| Genesis Molecular AI | 78% |
Sinopia Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 16, 2026 | ||||
| Grant | Mar 24, 2026 | ||||
| Grant | Dec 30, 2025 | ||||
| Grant | Sep 12, 2024 | ||||
| Grant | Apr 19, 2023 | ||||
Grant | Sep 27, 2021 |
Key People
Founding team and executive leadership
Sinopia Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| National Institute of Dental and Craniofacial Research | Grant |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 42% MoM.
- Jul 24, 2026
Monthly visitors increased 468% MoM.
Sinopia Biosciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sinopia Biosciences, Inc.'s valuation, stock price, and market status.
Is Sinopia Biosciences, Inc. a public or private company?
Sinopia Biosciences, Inc. is a private company.
What is the current stock price of Sinopia Biosciences, Inc.?
Sinopia Biosciences, Inc. is a private company with no public stock price. Caplight tracks Sinopia Biosciences, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Sinopia Biosciences, Inc. worth (valuation)?
Valuation information for Sinopia Biosciences, Inc. is not publicly available.
Can I buy Sinopia Biosciences, Inc. stock?
Sinopia Biosciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sinopia Biosciences, Inc.'s last funding round?
Sinopia Biosciences, Inc.'s most recent funding round was Seed Round on July 16, 2026.
Who are the main investors in Sinopia Biosciences, Inc.?
Key investors in Sinopia Biosciences, Inc. include National Cancer Institute, The Michael J. Fox Foundation for Parkinson's Research, National Institute of Dental and Craniofacial Research, National Institute of General Medical Sciences.
Will Sinopia Biosciences, Inc. IPO soon?
No public IPO plans have been announced for Sinopia Biosciences, Inc..
How can I track Sinopia Biosciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sinopia Biosciences, Inc.'s secondary market activity and sign up for updates.